Announce Date | 04/29/2024 |
EPS Normalized Actual | $0.57 (Beat by $1.01) |
EPS GAAP Actual | $0.57 (Beat by $1.01) |
Revenue Actual | $14.7648B |
Revenue Surprise | Beat by $14764.8M |
Announce Date | 09/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.53737 |
EPS GAAP Estimate | $1.53737 |
Revenue Estimate | $63.668516B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 22.63333 | 0.96 | 18.42562 | 26.75438 | 2 |
Dec 2026 | 76.39735 | 0.28 | 62.1945 | 90.30769 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.6 | 0.6 | 14.7648B | 46.22% | 14764.8M |
FQ4 2021 (Dec 2021) | 5.04 | 5.04 | 16.3877B | 42.49% | 16387.7M |
FQ3 2021 (Sep 2021) | 4.08 | 4.08 | 8.57B | -2.34% | 8570M |
FQ2 2021 (Jun 2021) | 1.4 | 1.4 | 7.92822B | -6.59% | 7928.22M |
FQ1 2021 (Mar 2021) | 4.64 | 4.64 | 7.94059B | -6.84% | 7940.59M |
FQ4 2020 (Dec 2020) | -8.32 | -8.32 | 9.42458B | -1.11% | 9424.58M |
FQ3 2020 (Sep 2020) | 0.0345969 | 0.0345969 | 8.77029B | 14.69% | 8770.29M |
FQ2 2020 (Jun 2020) | 7.16 | 7.16 | 8.45066B | 18.2% | 8450.66M |
FQ4 Announce Date
09/30/2024 (Pre-Market)
Consensus EPS Estimates
1.53737
Consensus Revenue Estimates
63.668516B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 26.92816 | -- | 26.08649 | 27.42289 | 0 |
FQ2 2026 (Jun 2026) | 25.622 | -- | 24.82116 | 26.09274 | 0 |
FQ1 2026 (Mar 2026) | 13.88029 | -- | 13.44645 | 14.1353 | 0 |
FQ4 2025 (Dec 2025) | 15.1284 | -- | 13.49278 | 15.77011 | 1 |
FQ3 2025 (Sep 2025) | 32.73928 | -- | 29.19965 | 34.128 | 1 |
FQ2 2025 (Jun 2025) | 25.15181 | -- | 22.4325 | 26.21869 | 1 |
FQ1 2025 (Mar 2025) | 14.52024 | -- | 12.95037 | 15.13615 | 1 |
FQ4 2024 (Dec 2024) | 12.69982 | -- | 11.32677 | 13.23851 | 0 |
FQ3 2024 (Sep 2024) | 1.53737 | -- | 1.50083 | 1.59479 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 42.14B | -- | 41.12B | 42.73B | 1 |
FQ2 2026 (Jun 2026) | 35.23B | -- | 34.38B | 35.73B | 1 |
FQ1 2026 (Mar 2026) | 28.86B | -- | 28.16B | 29.26B | 1 |
FQ4 2025 (Dec 2025) | 5.34B | -- | 4.89B | 5.51B | 0 |
FQ3 2025 (Sep 2025) | 6.2B | -- | 5.68B | 6.4B | 0 |
FQ2 2025 (Jun 2025) | 5.38B | -- | 4.93B | 5.56B | 0 |
FQ1 2025 (Mar 2025) | 4.25B | -- | 3.9B | 4.39B | 0 |
FQ4 2024 (Dec 2024) | 4.48B | -- | 4.11B | 4.63B | 1 |
FQ3 2024 (Sep 2024) | 63.67B | -- | 62.72B | 64.96B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.6 | 0.6 | 100% | |
FQ4 2021 (Dec 2021) | 5.04 | 5.04 | 100% | |
FQ3 2021 (Sep 2021) | 4.08 | 4.08 | 100% | |
FQ2 2021 (Jun 2021) | 1.4 | 1.4 | 100% | |
FQ1 2021 (Mar 2021) | 4.64 | 4.64 | 100% | |
FQ4 2020 (Dec 2020) | -8.32 | -8.32 | 100% | |
FQ3 2020 (Sep 2020) | 0.0345969 | 0.0345969 | 100% | |
FQ2 2020 (Jun 2020) | 7.16 | 7.16 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $14.76B | $14764.8M | 100% |
FQ4 2021 (Dec 2021) | $0B | $16.39B | $16387.7M | 100% |
FQ3 2021 (Sep 2021) | $0B | $8.57B | $8570M | 100% |
FQ2 2021 (Jun 2021) | $0B | $7.93B | $7928.22M | 100% |
FQ1 2021 (Mar 2021) | $0B | $7.94B | $7940.59M | 100% |
FQ4 2020 (Dec 2020) | $0B | $9.42B | $9424.58M | 100% |
FQ3 2020 (Sep 2020) | $0B | $8.77B | $8770.29M | 100% |
FQ2 2020 (Jun 2020) | $0B | $8.45B | $8450.66M | 100% |